Key Takeaways
- A disappointing year, but stabilization is visible: FY24 was weaker than expected, with top line down despite volume growth because of price drops driven by Chinese and domestic competition. Q4 showed prices stabilizing and volumes creeping up, halting the slide.
- Ethylamines are the bright spot: The new world-scale plant is running above expectations, margins have improved over the last 3-4 months as raw material costs softened and selling prices firmed, and capacity is now secured for the foreseeable future.
- Acetonitrile remains under Chinese siege: Utilization is stuck at ~55% under aggressive Chinese pricing. An anti-dumping duty investigation is underway, with interim relief being pursued, but a final outcome may take a year.
- Margin ambition is recovery, not a return to peaks: Management explicitly ruled out a return to FY21's exceptional margins and is targeting a climb back to average levels and a 20% EBITDA margin, driven by volume growth.
- What to watch next quarter: Whether the anti-dumping investigation on acetonitrile secures interim relief, any sign that Chinese competitive intensity is tapering, and progress on the two new-product capex decisions.
Demand & Competitive Environment
- Chinese overcapacity is the dominant force: Management stated that China, representing 55-60% of global chemical production, is the primary driver of disruption across the entire chemical industry, affecting both direct products and customers' products.
- Agrochemicals remain a drag: Destocking across the supply chain is still ongoing, though selective indicators suggest it may be nearing an end. Chinese competition has intensified, with low-priced agrochemical molecules flooding both Indian and international markets.
- Pricing has stopped falling, not started rising: The top-line slide halted because prices stabilized, not because they improved. Volumes are growing incrementally, and raw material costs may have a little further to soften, but management believes prices are near the bottom.
- Capex decisions are frozen by volatility: Management is hesitant to commit new capital while Chinese players remain so aggressive, fearing investment could be undercut. Decisions on new products and plant conversions will be taken in the next 3-6 months.
Kirat Patel: "currently, the market situation seems to be very volatile with the Chinese active so much that one hesitates to put capex in the ground and then find that the Chinese have under continued all over the world."
Product Segment Performance
| Segment | Trend | Commentary |
|---|---|---|
| Ethylamines | ▲ Improving | New plant at ~60% utilization, already exceeding old plant's maximum output. Margins improved over 3-4 months as ethyl alcohol costs softened and selling prices firmed marginally. Plant sized for 5-10 year demand view. |
| Methylamines | ▬ Stable, low growth | Base product growing at low single digits, constrained by weak agrochemical end-market. Derivatives growing slightly faster. Normal demand growth is 5-7% annually. |
| Acetonitrile | ▼ Under pressure | Utilization ~55% in H2 as Chinese aggressive selling continued. Pricing has stabilized but at depressed levels; difficult to call a bottom. Management believes its first-mover cost structure is lower than newer entrants. |
| Isopropylamines (MIPA) | ▼ Disappointing | Anti-dumping duty expired a year ago and was not renewed. Chinese players have re-entered actively, causing price pressure and market share loss. |
- Diethylketone (DEK): A final product, not further derivatized. Ramp-up has not been fully exploited yet and could contribute 1-2% to volume growth from a very low base.
Anti-Dumping & Trade Defence
- Acetonitrile investigation is the critical catalyst: An anti-dumping duty petition was filed in December, the investigation was initiated in March '24, and hearings are ongoing. Management is planning to file for interim relief, which could accelerate protection ahead of a final determination.
- Timeline is uncertain: Without interim relief, a final duty determination may take about a year from now, placing any outcome around Q4 FY25. The Chinese competitive dynamic is described as "very strange" and historically may last 1-1.5 years before easing.
Kirat Patel: "It's a very strange feature. So it's very difficult to predict when it will taper off."
Margins & Cost Structure
- Margin recovery is volume-led, not price-led: Management expects to get back to average margins and make up to the level of the year before last through sheer volume increase, not pricing power. The explicit target is a 20% EBITDA margin, with hope of reaching 20-22%.
- FY21 peaks are off the table: Margins will never return to those exceptional levels, per management. The ambition is normalization, not a super-cycle repeat.
- Power costs have eased: FY24 power costs were lower than FY23 because coal prices dropped considerably. A new solar plant at Dahej was commissioned in January and is already supplying electricity.
- Other expenses QoQ increase was one-off: The rise was driven by CSR provision catch-up, impairment of an unused Patalganga asset, and higher power and fuel from increased production. Nothing structural.
Kirat Patel: "I do not think that margins will ever go back to the 2021 levels because those were exceptional years."
Capacity & Capex
- Ethylamine capacity is now a multi-year solved problem: The new plant is probably the largest ethylamine plant in the world and takes care of capacity needs for the foreseeable future. No new ethylamine capacity will be needed again.
- Old ethylamine plant conversion planned: Engineering has started to convert the old ethylamine plant into methylamines capacity, timed for roughly two years out when demand growth will require it.
- Two new products under evaluation: Engineering is underway, with one near completion. These are not derivatives or part of the current amine portfolio. A decision to proceed will be taken in the next 3-6 months, with potential capex of ₹75-200 crores spread over two years.
- Near-term capex is maintenance-led: FY25 capex is guided at ₹60-80 crores, largely for maintenance and some debottlenecking. The larger growth capex decisions remain contingent on the competitive environment.
- Dahej land expansion on hold: An application for additional land has been submitted but no progress has been made. Management is not in a hurry and will likely act when the two new projects are under implementation, sometime in the next year or two.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | 10% growth expected; 10-15% is the historical norm | FY25 |
| EBITDA margin | Achieve 20%, with hope of 20-22% | FY25 |
| Acetonitrile utilization | Improve to 60-65% as market grows | FY25 |
| Capex (maintenance) | ₹60-80 crores for maintenance and debottlenecking | FY25 |
| New product capex decision | Decision on two new products; potential ₹75-200 crores additional capex | Next 3-6 months |
| Old ethyl-to-methyl plant conversion | Engineering started; capacity needed when demand grows into it | ~2 years out |
| Acetonitrile anti-dumping duty | Final determination expected, if favorable | ~Q4 FY25 (unless interim relief obtained) |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue | ₹1,440 cr (FY24), down ~14% YoY; average selling price dropped ~20% |
| Volume growth | Under 10% (FY24), volumes just short of 1 lac tons |
| EBITDA margin | 20% to 22% expected normal range; FY24 margins declined per kg vs pre-COVID |
| Total capex | ₹120 cr (FY24); ethylamine plant capitalized at ₹375 cr |
| Capex guidance | ₹60 cr to ₹80 cr planned for FY25, plus potential ₹75 cr to ₹200 cr for new products over 2 years |
| Ethylamine plant utilization | ~60% of new plant capacity in H2 FY24 |
| Acetonitrile plant utilization | ~55% in H2 FY24; outlook 60% to 65% |
| Methylamines capacity utilization | 80% to 85% of Dahej plant (45,000 tons/year capacity) |
| Diethylketone (DEK) utilization | 20% to 30% in FY24, volumes less than 1,000 tons |
| Exports share | 22% of sales in FY24; domestic 80%, exports 20% |
| Acetonitrile market size | 30,000 to 35,000 tons; 50% to 55% imported last year |
| Methylamines market size | 70,000 to 75,000 tons domestic production; potential 80,000 to 90,000 tons with downstream |
| Acetonitrile anti-dumping injury | 15% to 20% injury range; investigation initiated March '24, outcome expected Q4 FY25 |
| Solar power capacity | 8.5 MW total across sites; 3.5 MW commissioned in January at Dahej; annual savings ₹3 cr to ₹4 cr |
| Ammonia price | ₹50 to ₹52 per kg |
| Acetic acid price | A little shy of ₹40 per kg |
| Methanol price | Sub ₹30 per kg |